2026-2034年全球獸醫診斷市場規模、佔有率、趨勢和成長分析報告

全球獸醫診斷市場預計將從2025年的92.6億美元成長至2034年的214.1億美元，2026年至2034年的複合年成長率（CAGR）為9.76%。該市場的成長主要得益於寵物數量的增加以及畜牧養殖戶對動物健康、疾病預防和生產力的日益重視。獸醫診斷技術能夠早期識別感染疾病、代謝紊亂、遺傳性疾病和其他健康問題，從而實現及時治療並改善治療效果。寵物醫療保健支出的增加推動了獸醫診所採用先進診斷技術。同時，畜牧養殖戶也尋求可靠的檢測解決方案，以最大限度地減少疾病損失並維持生產力。預防獸醫學意識的提高進一步促進了對診斷服務和設備的需求。

技術進步使得檢測速度更快、準確度更高、日益分散化，從而創造了新的成長機會。分子診斷、免疫檢測、影像技術、臨床實驗室和即時檢測（POC​​）平台正變得越來越普及，獸醫專業人員能夠更便捷地使用這些技術。人們對通用感染疾病和抗生素抗藥性的日益關注，進一步凸顯了準確的治療前診斷的重要性。數位化獸醫平台和互聯診斷系統能夠改善數據管理和臨床決策。新興市場對動物健康基礎設施的投入不斷增加，預計將進一步加速這些技術的應用；同時，對牲畜疾病監測日益成長的需求，也促使各國政府和生產者加強檢測能力。

隨著獸醫學不斷朝向預防、早期檢測和個人化治療方向發展，其前景一片光明。伴侶動物日益被視為家庭成員，這推動了先進診斷服務的支出成長。在畜牧業領域，疾病監測和生物安全計畫預計將持續推動可靠檢測的需求。人工智慧、自動化檢測系統、攜帶式診斷設備和數位健康平台有望進一步提高診斷的速度和可及性。能夠提供經濟高效、準確且易於使用的解決方案的製造商有望從中受益。診斷公司、獸醫醫院、實驗室和動物健康組織之間的策略合作預計將支持市場的持續發展。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球獸醫診斷市場：依產品類型分類

• 市場分析、洞察與預測
• 裝置
• 試劑盒和試劑
• 軟體服務

第5章：全球獸醫診斷市場：依技術分類

• 市場分析、洞察與預測
• 免疫診斷
• 臨床生物化學
• 分子診斷
• 血液學
• 其他技術

第6章：全球獸醫診斷市場：依動物類型分類

• 市場分析、洞察與預測
• 伴侶動物（狗、貓和其他伴侶動物）
• 牲畜（牛、豬、家禽及其他牲畜）

第7章：全球獸醫診斷市場：依最終用戶分類

• 市場分析、洞察與預測
• 獸醫醫院和診所
• 參考實驗室
• 移動獸醫服務
• 研究機構和大學

第8章：全球獸醫診斷市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • BioChek BV
  • BioMerieux SA
  • BioNote Inc
  • Bio-Rad Laboratories Inc
  • Boehringer Ingelheim GmbH
  • Covetrus Inc
  • Danaher Corporation
  • Esaote SpA
  • Heska Corporation
  • IDEXX Laboratories Inc
  • IDVet
  • INDICAL Bioscience GmbH
  • Mindray Medical International Ltd
  • Neogen Corporation
  • QIAGEN NV
  • Randox Laboratories Ltd
  • Thermo Fisher Scientific Inc
  • Virbac SA
  • Zoetis Inc

The global veterinary diagnostics market size is expected to reach USD 21.41 Billion in 2034 from USD 9.26 Billion in 2025, growing at a CAGR of 9.76% during 2026-2034.This market is expanding as pet ownership increases and livestock producers place greater emphasis on animal health, disease prevention, and productivity. Veterinary diagnostics enable early identification of infectious diseases, metabolic disorders, genetic conditions, and other health problems, supporting timely treatment and better outcomes. Growing spending on companion animal healthcare is encouraging veterinary clinics to adopt advanced diagnostic technologies. At the same time, livestock producers are seeking reliable testing solutions to minimize disease-related losses and maintain productivity. Increasing awareness of preventive veterinary care is further supporting demand for diagnostic services and equipment.

Technological advancements are creating new growth opportunities through faster, more accurate, and increasingly decentralized testing. Molecular diagnostics, immunoassays, imaging technologies, laboratory testing, and point-of-care platforms are becoming more accessible to veterinary professionals. Rising concerns about zoonotic diseases and antimicrobial resistance are also increasing the importance of accurate diagnosis before treatment. Digital veterinary platforms and connected diagnostic systems can improve data management and clinical decision-making. Growing investment in animal health infrastructure across emerging markets is expected to expand adoption, while demand for livestock disease surveillance is encouraging governments and producers to strengthen testing capabilities.

The future outlook is positive as veterinary healthcare continues shifting toward prevention, early detection, and personalized treatment. Companion animals are increasingly viewed as family members, supporting higher spending on advanced diagnostic services. In livestock, disease surveillance and biosecurity programs should drive continued demand for reliable testing. Artificial intelligence, automated laboratory systems, portable diagnostics, and digital health platforms may further improve diagnostic speed and accessibility. Manufacturers that provide cost-effective, accurate, and user-friendly solutions are likely to benefit. Strategic partnerships between diagnostic companies, veterinary clinics, laboratories, and animal health organizations should support continued market development.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

• Instruments
• Kits and Reagents
• Software and Services

By Technology

• Immunodiagnostics
• Clinical Biochemistry
• Molecular Diagnostics
• Hematology
• Other Technologies

By Animal Type

• Companion Animals (Dogs, Cats, Other Companion Animals)
• Livestock Animals (Cattle, Swine, Poultry, Other Livestock Animals)

By End User

• Veterinary Hospitals & Clinics
• Reference Laboratories
• Ambulatory & Mobile Vet Services
• Research Institutes & Universities

COMPANIES PROFILED

• BioChek BV, BioMerieux SA, BioNote Inc., Bio-Rad Laboratories Inc., Boehringer Ingelheim GmbH, Covetrus Inc., Danaher Corporation, Esaote SpA, Heska Corporation, IDEXX Laboratories Inc., IDVet, INDICAL Bioscience GmbH, Mindray Medical International Ltd., Neogen Corporation, QIAGEN N.V., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., Virbac SA, Zoetis Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL VETERINARY DIAGNOSTICS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Kits and Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software and Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VETERINARY DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Immunodiagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Clinical Biochemistry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Hematology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VETERINARY DIAGNOSTICS MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Animal Type
• 6.2. Companion Animals (Dogs, Cats, Other Companion Animals) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Livestock Animals (Cattle, Swine, Poultry, Other Livestock Animals) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VETERINARY DIAGNOSTICS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Veterinary Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Reference Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Ambulatory & Mobile Vet Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Research Institutes & Universities Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL VETERINARY DIAGNOSTICS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Technology
  • 8.2.3 By Animal Type
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Technology
  • 8.3.3 By Animal Type
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Technology
  • 8.4.3 By Animal Type
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Technology
  • 8.5.3 By Animal Type
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Technology
  • 8.6.3 By Animal Type
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL VETERINARY DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 BioChek BV
  • 10.2.2 BioMerieux SA
  • 10.2.3 BioNote Inc
  • 10.2.4 Bio-Rad Laboratories Inc
  • 10.2.5 Boehringer Ingelheim GmbH
  • 10.2.6 Covetrus Inc
  • 10.2.7 Danaher Corporation
  • 10.2.8 Esaote SpA
  • 10.2.9 Heska Corporation
  • 10.2.10 IDEXX Laboratories Inc
  • 10.2.11 IDVet
  • 10.2.12 INDICAL Bioscience GmbH
  • 10.2.13 Mindray Medical International Ltd
  • 10.2.14 Neogen Corporation
  • 10.2.15 QIAGEN N.V
  • 10.2.16 Randox Laboratories Ltd
  • 10.2.17 Thermo Fisher Scientific Inc
  • 10.2.18 Virbac SA
  • 10.2.19 Zoetis Inc